APA aipamena

Lavalle-González, F. J., Januszewicz, A., Davidson, J., Tong, C., Qiu, R., Canovatchel, W., & Meininger, G. (2013). Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: A randomised trial. Springer Berlin Heidelberg.

Chicago Style aipamena

Lavalle-González, F. J., A. Januszewicz, J. Davidson, C. Tong, R. Qiu, W. Canovatchel, and G. Meininger. Efficacy and Safety of Canagliflozin Compared With Placebo and Sitagliptin in Patients With Type 2 Diabetes On Background Metformin Monotherapy: A Randomised Trial. Springer Berlin Heidelberg, 2013.

MLA aipamena

Lavalle-González, F. J., et al. Efficacy and Safety of Canagliflozin Compared With Placebo and Sitagliptin in Patients With Type 2 Diabetes On Background Metformin Monotherapy: A Randomised Trial. Springer Berlin Heidelberg, 2013.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.